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Primary dermal ﬁbroblasts from H0012 (female, 50 years, low-
steatosis) were reprogrammed by transduction of a combination of
two episomal-based plasmids (7F1) expressing OCT4, SOX2, NANOG,(J. Adjaye).
. This is an open access article underLIN28, c-Myc and KLF-4 (H0012; Yu et al., 2011). iPSCs expressed the
pluripotency-associated transcription factors OCT4, NANOG, SOX2 and
cell surfacemarkers SSEA-4, TRA-1-60, TRA-1-81. Pluripotency was fur-
ther demonstrated in vitro by embryoid body (EB)-based differentiation
to the three germ layers endoderm, ectoderm, andmesoderm. DNA ﬁn-
gerprinting conﬁrmed the origin of both iPSC lines, while karyogram re-
vealed a 46,XX,t(7;10)(q11;p12) karyotype for S12.
Materials and methods
Patient recruitment, sample collection and clinical measurements
The study was approved by the institutional review board of the
Medical University of Graz (reg. IRB00002556 at the Ofﬁce for Human
Research Protections of the US Departments of Health and Human Ser-
vices) under license 20–143 ex 08/09. For more details seeWruck et al.
(2015) (Table 1).
Cell culture
For the cultivation of primary ﬁbroblast cells high-glucose
Dulbecco's Modiﬁed Eagle's Medium (DMEM) substitutedwith 1% Pen-
icillin-Streptomycin (Penstrep), 1% Glutamine and 10% fetal calf serum
(FCS) at 37 °C and 5% CO2 was used. IPS cells were cultured in Essential
8 (E8) Medium with 1% Penstrep on Matrigel or mouse embryonic ﬁ-
broblasts (MEFs) as a feeder layer at 37 °C and 5% CO2. All cell lines
were split and replated weekly.
Derivation of iPSCs
S12 was reprogrammed by the nucleofection of an episomal-based
plasmid combination (7F1) expressing the reprogramming factorsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of H0012-derived iPSC line S12. The iPSC line S12 was characterized by ICC for the pluripotency markers OCT4, SOX2 and NANOG (A) and SSEA4, TRA-1-60 and
TRA-1-81 (A). (Scale bar: 200 μm). Pluripotency was conﬁrmed by EB formation (B) and subsequent ICC for ectodermal (NESTIN), mesodermal (SMA) and endodermal (SOX17)
markers. (Scale bar: 100 μm). The origin of iPSC line S12 was determined by karyotype (C) and DNA-ﬁngerprinting (D). DNA ﬁngerprinting conﬁrmed the origin of the iPSC line
employing Primers D7S796 (Jozefczuk et al., 2012) and D21S2055 (Yu et al., 2011), the karyogram revealed a 46,XX,t(7;10)(q11;p12) karyotype.
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Nucleofection was achieved using a cell-speciﬁc Amaxa Cell Line
Nucleofector Kit (Lonza) and transfected cells were supplemented
with TGFβ-inhibitor (SB431245, Sigma, 2 μM), a MEK inhibitor
(PD0325901, Sigma, 1 μM) and a GSK3β inhibitor (CHIR99021, Sigma,
3 μM).
DNA ﬁngerprinting analysis
The STR analysis was performed by PCR ampliﬁcation using the fol-
lowing primer sequences (5′–3′): D17S1290 forward
GCAACAGAGCAAGACTGTC, reverse GGAAACAGTTAAATGGCCAA; and
D21S2055 forward AACAGAACCAATAGGCTATCTATC and reverse
TACAGTAAATCACTTGGTAGGAGA.
Embryoid body formation
To conﬁrm pluripotency of the cultured iPSCs EB formationwas per-
formed as described inMatz and Adjaye (2015) and ICC to visualize dif-
ferentiation we employed markers for all three germ layers. As primaryantibodies SMA (1:100, Cell Signalling Technology®) was used to iden-
tify mesodermal differentiation. SOX17 (1:50, R&D Systems) for endo-
dermal differentiation and Nestin (1:500, Sigma-Aldrich) ectoderm.
Co-staining was accomplished using nuclear Hoechst (1:5000). Images
were captured using a ﬂuorescence microscope (AxioVision).Immunoﬂuorescence-based detection of pluripotency associated proteins
The following primary antibodies were used- SOX2 (1:400, Cell Sig-
nalling Technology®), OCT4 (1:400, Cell Signalling Technology®),
NANOG (1:800, Cell Signalling Technology®), TRA-1-60 (1:1000, Cell
Signalling Technology®), TRA-1-81 (1:1000, Cell Signalling Technolo-
gy®) and SSEA4, (1:1000, Cell Signalling Technology®). After several
washing steps the secondary antibody incubation (1:500, anti-mouse-
Cy3 (Thermo Fisher Scientiﬁc), anti-mouse-Alexa488 (Thermo Fisher
Scientiﬁc), anti-rabbit-Alexa488 (Thermo Fisher Scientiﬁc)) was per-
formed for 1 h at room temperature (RT) avoiding light exposure. To vi-
sualize the localization of all cells nuclear Hoechst (1:5000) co-staining
was accomplished. Images were captured by using a ﬂuorescence mi-
croscope (AxioVision).
Fig. 2.Microarray-based transcriptome analysis. Dendrogram generated from the transcriptomes of patient's ﬁbroblasts (Fibroblasts), embryonic stem cells (H1_ES) and the retroviral-
derived iPSC line (S12_iPS).
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Karyotype analysis was performed at the Institute of Human Genet-
ics and Anthropology, Heinrich-Heine-University, Düsseldorf.Microarray-based transcriptome analysis
Transcriptome analysis was carried out on the Affymetrix microar-
ray platform. For each sample, 1 μg quality-checked total RNA were
used as input. RNA hybridizations were carried out by the Biologisch-
medizinisches Forschungszentrum (BMFZ), Heinrich-Heine University,
Düsseldorf. The correlation values were calculated using the Gene Ex-
pression Module of the software R/Bioconductor (Affymetrix). Correla-
tion coefﬁcient of S12 iPSCs and H1 ESCs is 0.9251.Table 1
Clinical background of donor primary ﬁbroblast cell line.
H0012
Gender F
Age 50
BMI 35
Steatosis 0%
Operation Bariatric surgery
Steatosis grade group Obese, low steatosis
Waist 120
Hip 130
RR syst/blood pressure ND
T2DM Y
Hypertension Y
ALT 17
AST 24
GGT 20
Fasting glucose 70
Insulin ND
HOMA-IR ND
CHOL 249
TRIG 57
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